Fabiano Pieroni
YOU?
Author Swipe
View article: CONDICIONAMENTO MIELOABLATIVO DE TOXICIDADE REDUZIDA NO TRANSPLANTE DE CÉLULAS PROGENITORAS HEMATOPOÉTICAS ALOGÊNICO PARA TRATAMENTO DA DOENÇA FALCIFORME EM CRIANÇAS E ADULTOS: EXPERIÊNCIA DE UM ÚNICO CENTRO BRASILEIRO
CONDICIONAMENTO MIELOABLATIVO DE TOXICIDADE REDUZIDA NO TRANSPLANTE DE CÉLULAS PROGENITORAS HEMATOPOÉTICAS ALOGÊNICO PARA TRATAMENTO DA DOENÇA FALCIFORME EM CRIANÇAS E ADULTOS: EXPERIÊNCIA DE UM ÚNICO CENTRO BRASILEIRO Open
View article: FATORES ASSOCIADOS À QUALIDADE DE VIDA RELACIONADA À SAÚDE DE PACIENTES COM DOENÇA DO ENXERTO CONTRA O HOSPEDEIRO
FATORES ASSOCIADOS À QUALIDADE DE VIDA RELACIONADA À SAÚDE DE PACIENTES COM DOENÇA DO ENXERTO CONTRA O HOSPEDEIRO Open
Introdução e objetivo: A doença do enxerto contra o hospedeiro (DECH) acarreta considerável sofrimento emocional ao paciente, contribuindo para a depreciação de sua qualidade de vida (QV). Este estudo teve como objetivo avaliar a QV de pac…
View article: TRANSPLANTE DE CÉLULAS PROGENITORAS HEMATOPOÉTICAS ALOGÊNICO PARA TRATAMENTO DA DOENÇA FALCIFORME: RESULTADOS DE UM ÚNICO CENTRO BRASILEIRO
TRANSPLANTE DE CÉLULAS PROGENITORAS HEMATOPOÉTICAS ALOGÊNICO PARA TRATAMENTO DA DOENÇA FALCIFORME: RESULTADOS DE UM ÚNICO CENTRO BRASILEIRO Open
Introdução: A Doença Falciforme (DF), caracterizada pela presença de hemólise, crises vaso-oclusivas, dano endotelial e inflamação crônica, é a hemoglobinopatia hereditária mais prevalente no mundo. No Brasil, o risco de óbito entre 1 e 9 …
View article: HLA-identical sibling hematopoietic stem cell transplantation following reduced-toxicity myeloablative conditioning regimen in sickle cell disease
HLA-identical sibling hematopoietic stem cell transplantation following reduced-toxicity myeloablative conditioning regimen in sickle cell disease Open
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only widely available curative treatment for sickle cell disease (SCD). Myeloablative conditioning regimens are associated with excellent outcomes in children with HLA-identi…
View article: Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients Open
Objectives Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) is the only currently available curative treatment for sickle cell disease (SCD). Here, we comprehensively evaluated the reconstitution of T‐ and B‐cell compartment…
View article: Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients
Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients Open
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only currently available curative treatment for sickle cell disease (SCD). However, the effects of HSCT on SCD pathophysiology are poorly elucidated. Here, we assessed r…
View article: Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients
Hematopoietic stem cell transplantation reverses white matter injury measured by diffusion-tensor imaging (DTI) in sickle cell disease patients Open
View article: Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single‐institution experience
Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single‐institution experience Open
Sickle cell disease (SCD) is the most prevalent monogenic disease in the world.1 In Brazil, SCD affects approximately 30 000 people, with 3 500 new patients born each year.2 SCD is characterized by haemolytic anaemia and organ injury. Trea…
View article: Clinical studies using stem cells for treatment of retinal diseases: state of the art
Clinical studies using stem cells for treatment of retinal diseases: state of the art Open
Degenerative retinal diseases such as retinitis pigmentosa, Stargardt's macular dystrophy, and age-related macular degeneration are characterized by irreversible loss of vision due to direct or indirect photoreceptor damage. No effective t…
View article: Clinical studies using stem cells for treatment of retinal diseases: state of the art
Clinical studies using stem cells for treatment of retinal diseases: state of the art Open
Degenerative retinal diseases such as retinitis pigmentosa, Stargardt’s macular dystrophy, and age-related macular degeneration are characterized by irreversible loss of vision due to direct or indirect photoreceptor damage. No effective t…
View article: Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes Open
Autologous hematopoietic stem cell transplantation (AHSCT) increases C-peptide levels and induces insulin independence in patients with type 1 diabetes. This study aimed to investigate how clinical outcomes may associate with the immunolog…
View article: Allogenic bone narrow transplantation in sickle-cell diseases.
Allogenic bone narrow transplantation in sickle-cell diseases. Open
SUMMARY Sickle-cell diseases are the most common inherited hemoglobinopathies worldwide. Improvement in survival has been seen in the last decades with the introduction of careful screening and prevention of complications and the introduct…